Unique ID issued by UMIN | UMIN000033569 |
---|---|
Receipt number | R000038282 |
Scientific Title | Evaluation of the effect of the black tea-derived aroma on automatic nervous system and cerebral blood flow in healthy adults. |
Date of disclosure of the study information | 2019/10/31 |
Last modified on | 2018/07/31 08:58:24 |
Evaluation of the effect of the black tea-derived aroma on automatic nervous system and cerebral blood flow in healthy adults.
Evaluation of the effect of the black tea-derived aroma on automatic nervous system and cerebral blood flow in healthy adults.
Evaluation of the effect of the black tea-derived aroma on automatic nervous system and cerebral blood flow in healthy adults.
Evaluation of the effect of the black tea-derived aroma on automatic nervous system and cerebral blood flow in healthy adults.
Japan |
None (Healthy adults)
Adult |
Others
NO
To investigate the efficacy of the black tea-derived aroma on autonomic nervous system and cerebral blood flow.
Efficacy
Pupillary reaction to light
Cerebral blood flow
Cognitive tasks
Questionnaires
Interventional
Single arm
Non-randomized
Open -no one is blinded
Self control
1
Treatment
Food |
inhalation of black tea flavor
20 | years-old | <= |
65 | years-old | >= |
Male and Female
1) Individuals aged from 20 to 65 years, when giving the informed consent.
2) Individuals giving the written informed consent.
1) Individuals who declare the allergy symptoms against test diets.
2) Individuals who have anamnesis of cranial nerve disease.
3) Individuals who have anamnesis of the autonomic nervous system.
4) Individuals who have mental symptoms, or who have been diagnosed as mental disorder.
5) Individuals who are being treated with hormone, or who have been diagnosed as menopausal symptoms
6) Individuals who can't perform the study because it's olfactory impairment.
7) Individuals who regularly take drugs or health foods affecting cognitive functions
8) Individuals who regularly take drugs of health foods affecting autonomic nervous system.
9) Individuals who is not suitable for subjects by pre-test questionnaire.
10) Individuals who are planned to participate in other clinical study.
11) Individuals who are pregnant or breastfeeding during the study.
12) Individuals who sometimes have irregular lifestyles during the study.
13) Individuals who are judged as unsuitable for the study by the investigator for other reason.
7
1st name | |
Middle name | |
Last name | Keiko Kobayashi |
Kirin Company, Limited
Research and Development Division, Research Laboratories for Health Science & Food Technologies
1-13-5, Fukuura Kanazawa-ku, Yokohama, Japan
080-2016-9331
keiko_kobayashi@kirin.co.jp
1st name | |
Middle name | |
Last name | Keiko Kobayashi |
Kirin Company, Limited
Research and Development Division, Research Laboratories for Health Science & Food Technologies
1-13-5, Fukuura Kanazawa-ku, Yokohama, Japan
080-2016-9331
keiko_kobayashi@kirin.co.jp
Kirin Company, Limited
None
Self funding
NO
2019 | Year | 10 | Month | 31 | Day |
Unpublished
Preinitiation
2018 | Year | 06 | Month | 29 | Day |
2018 | Year | 08 | Month | 01 | Day |
2018 | Year | 07 | Month | 31 | Day |
2018 | Year | 07 | Month | 31 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000038282